AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Asetek A/S

Share Issue/Capital Change Apr 18, 2023

6301_rns_2023-04-18_acfb7806-efc3-47ec-b754-d0f6a358a7e3.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Asetek A/S - Publication of prospectus and terms of the fully underwritten Rights Issue

Asetek A/S - Publication of prospectus and terms of the fully underwritten Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED

STATES OF AMERICA, CANADA, AUSTRALIA, OR JAPAN OR ANY OTHER JURISDICTION IN

WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

Asetek A/S (the "Company" or "Asetek") today announces the initiation of a

rights issue (the "Rights Issue") at a subscription ratio of 1:1 and

subscription price of NOK 3 per new share. The Rights Issue comprises 71,166,667

new shares, which are issued with preemptive rights to subscribe for the new

shares for the Company's existing shareholders. This announcement is not a

prospectus. A prospectus regarding the Rights Issue is available on the

Company's website https://ir.asetek.com/ (https://ir.asetek.com/share

-info/prospectus/default.aspx) (subject to certain restrictions).

The key terms of the Rights Issue are the following:

· The Rights Issue comprises 71,166,667 new shares with a nominal value of DKK

0.10 each

· The subscription price is NOK 3 per new share

· The gross proceeds of the Rights Issue will be approximately DKK 140 million

· Each of the Company's existing shareholders will be allocated 2.621508

preemptive rights for each existing share held, rounded down to the nearest

whole preemptive right

· The subscription ratio of the Rights Issue is 1:1, meaning that one (1)

preemptive right will entitle the holder to subscribe for one (1) new share

· Existing shares traded after 19 April 2023 will be traded without preemptive

rights, provided that the existing shares are traded with the customary two-day

settlement

· The preemptive rights is expected to be traded on Oslo Børs in the period

commencing on 24 April 2023 and closing on 2 May 2023 at 4:30 p.m. CEST

· The subscription period for new shares commences on 24 April 2023 and closes

on 8 May 2023 at 4:30 p.m. CEST

· Admission to trading of the preemptive rights is subject to final approval

by Oslo Børs. Any preemptive rights that are not exercised during the

subscription period will lapse with no value, and the holder of such preemptive

subscription rights will not be entitled to compensation. Such remaining shares

may be subscribed for by existing shareholders of the Company investors during

the subscription period

Investors are advised to carefully read and consider the information included in

the prospectus, including section 1 "Risk Factors" and section 12.1 "Background

for the Offering and use of proceeds". The prospectus including the risk factors

set out therein are considered to contain important information regarding the

risks associated with an investment in Asetek.

Background of the Rights Issue and use of proceeds

Reference is made to the stock exchange announcements published by Asetek on 8

March 2023, 21 March 2023 and 31 March 2023 regarding the proposal by the

Company's board of directors to carry out a fully underwritten rights issue in

the Company to raise gross proceeds corresponding to the NOK equivalent of

approximately DKK 140,000,000 to cover its expected working capital short fall.

As announced, the Company believes that its cash position and the liquidity

available from its operations, external borrowings and other sources currently

available is sufficient to satisfy its working capital requirements until around

mid-May, 2023. From then on, the Company expects a cash shortfall, mainly as a

result of cash balances (including cash inflows from operations) being allocated

to capital expenditures related to the construction of a new headquarter

facility - reference is made to risk factor 1.1.3.1 of the prospectus in this

regard. On that basis, the Company's primary provider of credit facilities has

requested an equity capital injection in order to continue the credit

facilities, which are necessary for the Company to service its payment

obligations. Moreover, the Company also notes that in the financial statements

for the financial year ended 31 December 2022, the Company's auditor expressed

an emphasis of matter in relation to the Company's ability to continue as going

concern in 2023 and has provided the following in its audit report "we draw

attention to Note 1.1 in the consolidated financial statements, which describe

that the budgeted liquidity may be insufficient during 2023 and is dependent on

the current level of forecasted cash flow until the planned capital increase

later in 2023 and the completion and the amount of cash from the planned capital

increase. This indicates that a material uncertainty exists that may cast

significant doubt on the Group's ability to continue going concern. Our opinion

is not modified in respect of this matter.".

The proceeds from the Rights Issue are expected to strengthen the Company's

financial position by optimizing its balance sheet and cover its cash shortfall.

This will be based on increasing available cash for committed capex investments

for the new headquarter facility. If funding is not established through the

Rights Issue or otherwise, the Company will need to take mitigating actions,

such as cut costs and pursue sale of certain Group assets, such as sale and

leaseback of certain assets.

Main terms of the Rights Issue

Below is a summary of the main terms of the Rights Issue. Reference is made to

the prospectus for a detailed description of the terms of the rights issue.

· The Rights Issue: The Rights Issue comprises 71,166,667 new shares with a

nominal value of DKK 0.10 each with preemptive rights for the Company's existing

shareholders.

· Subscription price: The new shares are offered at a subscription price of

NOK 3 per new share, which represents a discount of 41.8% to the theoretical

share price exclusive of the preemptive rights based on the volume-weighted

average price of the Company's shares on Oslo Børs yesterday, 17 April 2023.

· Subscription ratio: Each existing shareholder as of 19 April 2023 (and being

registered as such in Euronext Securities Oslo, the Norwegian Central Securities

Depository, the "VPS" as at the expiry of 21 April 2023 (the "Record Date") will

be granted 2.621508 preemptive rights for each share registered as held by the

shareholder, rounded down to the nearest whole preemptive right. The

subscription ratio for the Rights Issue is 1:1, which means that one (1)

preemptive right will entitle the holder to subscribe for one (1) new share with

a nominal value of DKK 0.10 each.

· Trading in preemptive subscription rights: The preemptive rights are

tradable and will, subject to final approval by Oslo Børs, be traded on Oslo

Børs under the ISIN code DK0062492997 and ticker "ASTKT" from 09:00 a.m. (CEST)

24 April 2023 to 4:30 p.m. (CEST) on 2 May 2023.

· Subscription period: The subscription period for the new shares commences on

24 April 2023 and closes on 8 May 2023 at 4:30 p.m. CEST. Any preemptive rights

that are not exercised during this subscription period will lapse with no value,

and the holder of such preemptive subscription rights will not be entitled to

any compensation.

· Payment and delivery: Upon exercise of the preemptive subscription right,

the holder must pay NOK 3 per new share subscribed for. Payment of the new

shares shall be made in NOK with Carnegie AS or Skandinaviska Enskilda Banken AB

(publ) no later than 12 May 2023.

· Remaining shares: New shares not subscribed for by exercise of a preemptive

right may be subscribed for by existing shareholders or investors, who before

the expiry of the subscription period have made binding undertakings to

subscribe for the remaining shares according to a separate subscription form

contained in the prospectus. In case of oversubscription of remaining shares,

such remaining shares will be allocated according to appointment keys set out in

the prospectus.

· Underwriting: The Rights Issue is fully underwritten through advance

subscription commitments and guarantee undertakings entered into between the

Company and a number of existing shareholders and other investors, subject to

satisfaction of certain conditions further described in the prospectus prepared

by the CompanyThe Rights Issue is not underwritten by the joint global

coordinators and joint bookrunners.

· Trading and official listing of new shares: Subject to timely payment of the

entire subscription amount in the Rights Issue, the Company expects that the

share capital increase pertaining to the Rights Issue will be registered with

the Danish Business Authority on or about 15 May 2023 and that the New Shares

will be delivered to the VPS accounts of the subscribers to whom they are

allocated on or about the next day (i.e. on or about 16 May 2023). The New

Shares cannot be traded before they are issued and delivered in the VPS.

The new shares are expected to be admitted to trading and listing on Oslo Børs

under the ISIN code for the Company's existing shares DK0060477263 on or around

16 May 2020.

· Withdrawal of the Rights Issue: The Rights Issue may be withdrawn by the

Company, subject to certain conditions, before registration of the capital

increase relating to the new shares with the Danish Business Authority.

If the Rights Issue is withdrawn, any exercise of preemptive rights that has

already taken place will be cancelled automatically. Any paid subscription

amounts for the new shares will be refunded to the subscriber (less any

transaction costs). All preemptive rights will lapse, and no new shares will be

issued.

Trades of preemptive rights executed during the rights trading period will,

however, not be affected. Consequently, investors who have acquired preemptive

rights will incur a loss corresponding to the purchase price of the preemptive

rights and any transaction costs.

Investors in the Rights Issue who have subscribed for, been allocated and paid

the subscription amount for new shares will receive a refund of the subscription

amount for the new shares (less any transaction costs). Consequently, such

subscribers of new shares may incur a loss corresponding to the difference

between the purchase price for preemptive rights and the subscription price of

the new shares and any related transaction costs.

The Company is not liable for any losses that investors may suffer as a result

of withdrawal of the Rights Issue including but not limited to, any transaction

costs or lost interest.

Any such withdrawal will be notified via Oslo Børs.

The full terms and conditions of the Rights Issue and other circumstances that

must be considered upon subscription for shares in the Rights Issue are included

in the prospectus prepared by the Company in connection with the Rights Issue.

The prospectus can be obtained on the Company's website https://ir.asetek.com/

(subject to certain restrictions). Prospective investors should read the

prospectus for a discussion of certain risks that shareholders and investors

should consider before investing in the preemptive rights and the shares.

Admission to trading and official listing on Nasdaq Copenhagen A/S

The Company intends to complete a dual-listing and has today made an application

for the shares of the Company to be admitted to trading and official listing on

Nasdaq Copenhagen A/S ("Nasdaq Copenhagen") (in the form of share entitlements).

The shares will, subject to no material events occurring prior to, be admitted

to trading and official listing on Nasdaq Copenhagen in the same ISIN code as

the existing shares (in the form of share entitlements). The first day of

trading and official listing of the shares (in the form of share entitlements)

of the Company on Nasdaq Copenhagen is expected to be 17 May 2023. Shareholders

wishing to trade their shares on Nasdaq Copenhagen must transfer such shares to

VP Securities' securities system. Such transfers may be subject to fees levied

by the settlement parties in accordance with their respective fee schedules.

The Company has entered into a market maker agreement with Carnegie Investment

Bank AB (Publ) to ensure liquidity in the Company's shares traded (in the form

of share entitlements) on Nasdaq Copenhagen.

Potential delisting from Oslo Børs

Following, and subject to, completion of the Rights Issue and the admission to

trading on Nasdaq Copenhagen, the Company intends to apply for the Shares to be

delisted from Oslo Børs, which is subject to, among other things, approval by

the requisite majority of Company's general meeting and Oslo Børs. There can be

no assurances as to when the delisting from Oslo Børs will be effectuated, if at

all.

Expected timetable

The following table presents the expected timetable of principal events:

[]

Publication of

18

Prospectus.......................................................................

. April

2023

Last trading day in Existing Shares including Preemptive

Rights[1]............... 19

April

2023

First day of trading in Existing Shares excluding Preemptive Rights...........

20

April

2023

Record Date of Preemptive

21

Rights[1)].........................................................

April

2023

Rights Trading Period on Oslo Børs

commences...................................... 24

April

2023

at

9:00

a.m.

(CEST)

Subscription Period for New Shares

commences...................................... 24

April

2023

at

9:00

a.m.

(CEST)

Rights Trading Period on Oslo Børs

closes.............................................. 2 May

2023

at

4:30

p.m.

(CEST)

Subscription Period for the New Shares

closes......................................... 8 May

2023

at

4:30

p.m.

(CEST)

Expected publication of result of the

Offering............................................ 10 May

2023

Allocation of New Shares not subscribed for by exercise of Preemptive Rights

(the Remaining 10 May

Shares)................................................................

2023

Payment

12 May

Date.............................................................................

........... 2023

Registration of the share capital increase regarding the New Shares with the

Danish Business On or

Authority.................................................................

about

15

May

2023

Delivery of the New

On or

Shares.....................................................................

about

16

May

2023

First day of trading of the New Shares on Oslo

Børs................................. On or

about

16

May

2023

First day of trading and official listing of the Shares (in the form of share

entitlements) On or

on Nasdaq Copenhagen ....................................................

about

17

May

2023

Joint Global Coordinators and legal advisors

Carnegie AS and Skadinaviska Enskilda Banken AB (publ.) (SEB) are acting as

joint global coordinators and joint bookrunners in the Rights Issue (the

"Managers"). Kromann Reumert is acting as Danish legal advisors to the Company.

Advokatfirmaet Wiersholm AS and Gorrissen Federspiel Advokatpartnerselskab are

acting as Norwegian or Danish, respectively, legal advisors to the Managers.

Prospectus

Following publication, the prospectus containing detailed information on the

Company and the Rights Issue will, subject to certain restrictions, be available

on the Company's website https://ir.asetek.com/. Apart from information that is

incorporated into the prospectus by reference, the contents of the website of

the Company does not form part of the prospectus.

For further information, please contact:

Peter Dam Madsen

Chief Financial Officer

Mobile: +45 2080 7200

e-mail: [email protected]

About Asetek A/S

Asetek (ASTK.OL), a global leader in mechatronic innovation, is a Danish garage

-to-stock-exchange success story. Founded in 2000, Asetek established its

innovative position as the leading OEM developer and producer of the all-in-one

liquid cooler for all major PC & Enthusiast gaming brands. In 2013, Asetek went

public while expanding into energy-efficient and environmentally friendly

cooling solutions for data centers. In 2021, Asetek introduced its line of

products for next level immersive SimSports gaming experiences. Asetek is

headquartered in Denmark and has operations in China, Taiwan and the United

States.

IMPORTANT INFORMATION

This announcement does not constitute an offer for sale of, or a solicitation of

an offer to purchase or subscribe for, any securities in the United States.

Securities may not be offered or sold in the United States unless they are

registered or are exempt from registration under the U.S. Securities Act of

1933, as amended. The information contained in this announcement is for

informational purposes only and does not purport to be full or completed. The

Company does not intend to register any portion of this offering in the United

States or to conduct a public offering in the United States. Copies of this

announcement are not being, and should not be, distributed in or sent into the

United States.

In the United Kingdom, this announcement is for distribution only to and is

directed only at persons who (i) have professional experience in matters

relating to investments which fall within Article 19(5) of the Financial

Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the

"Financial Promotion Order"), (ii) are persons falling within Article 49(2)(a)

to (d) ("high net worth companies, unincorporated associations etc") of the

Financial Promotion Order, or (iii) are persons to whom an invitation or

inducement to engage in investment activity (within the meaning of section 21 of

the Financial Services and Markets Act 2000) in connection with the issue or

sale of any securities may otherwise lawfully be communicated or caused to be

communicated (all such persons together being referred to as "relevant

persons"). This announcement is directed only at relevant persons and must not

be acted on or relied on by persons who are not relevant persons. Any investment

or investment activity to which this announcement relates is available only to

relevant persons and will be engaged in only with relevant persons.

This announcement has been prepared on the basis that any offer of securities in

any Member State of the European Economic Area, other than Denmark and Norway,

which has implemented the Prospectus Regulation (EU) (2017/1129, as amended, the

"Prospectus Regulation") (each, a "Relevant Member State") will be made pursuant

to an exemption under the Prospectus Regulation, as implemented in that Relevant

Member State, from the requirement to publish a prospectus for offers of

securities. Accordingly any person making or intending to make any offer in that

Relevant Member State of securities which are the subject of the offering

contemplated in this announcement, may only do so in circumstances in which no

obligation arises for the Company or any of the Managers to publish a prospectus

pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus

pursuant to Article 16 of the Prospectus Regulation, in each case, in relation

to such offer. Neither the Company nor any of the Managers have authorized, nor

do they authorize, the making of any offer of the securities through any

financial intermediary, other than offers made by the Managers which constitute

the final placement of the securities contemplated in this announcement. Neither

the Company nor any of the Managers have authorized, nor do they authorize, the

making of any offer of securities in circumstances in which an obligation arises

for the Company or any Managers to publish or supplement a prospectus for such

offer.

The distribution of this announcement and other information may be restricted by

law in certain jurisdictions. Persons into whose possession this announcement or

such other information should come are required to inform themselves about and

to observe any such restrictions.

The Managers and/or any of their affiliates or any of their respective

directors, officers, employees, advisers, agents or any other person(s) do not

accept any responsibility or liability whatsoever for, or make any

representation or warranty, express or implied, as to the accuracy, completeness

or fairness of the information or opinions in this announcement (or whether any

information has been omitted from this announcement) or any other information

relating the Company or associated companies. The Managers are acting

exclusively for the Company and no-one else in connection with the Rights Issue

and will not regard any other person as their client in relation to the Rights

Issue and will not be responsible to anyone other than the Company for providing

the protections afforded to their clients.

This announcement is for information purposes only and is not to be relied upon

in substitution for the exercise of independent judgment. It is not intended as

investment advice and under no circumstances is it to be used or considered as

an offer to sell, or a solicitation of an offer to buy any securities or a

recommendation to buy or sell any securities of the Company.

Forward looking statements

This announcement includes forward-looking statements which may include

statements regarding the Company's business strategy, financial condition,

profitability, results of operations and market data, as well as other

statements that are not historical facts. Words such as "believe," "anticipate,"

"plan," "expect," "target," "estimate," "project," "predict," "forecast,"

"guideline," "should," "aim," "continue," "could," "guidance," "may,"

"potential," "will," as well as similar expressions and the negative of such

expressions are intended to identify forward-looking statements, but are not the

exclusive means of identifying these statements. By their nature, forward

-looking statements are subject to numerous factors, risks and uncertainties

that could cause actual outcomes and results to be materially different from

those projected. Readers are cautioned not to place undue reliance on these

forward-looking statements. Except for any ongoing obligation to disclose

material information as required by the applicable law, the Company does not

have any intention or obligation to publicly update or revise any forward

-looking statements after it distributes this announcement, whether to reflect

any future events or circumstances or otherwise.

[1] Trading in Shares after the last trading day in Existing Shares including

Preemptive Rights on 19 April 2023 will be exclusive of rights to receive

Preemptive Rights for the buyer.

Talk to a Data Expert

Have a question? We'll get back to you promptly.